What are the pharmacotherapeutic considerations for the treatment of myasthenia gravis?

被引：6

作者：

Vanoli, Fiammetta ^{[1
,2
]}

Mantegazza, Renato ^{[1
]}

机构：

[1] Fdn IRCCS Ist Neurol Carlo Besta, Neuroimmunol & Neuromuscular Dis Dept, Milan, Italy

[2] Sapienza Univ Rome, Dept Human Neurosci, Rome, Italy

来源：

关键词：

Myasthenia gravis; monoclonal antibodies; immunosuppression; biological drugs; C5; FcRn; RITUXIMAB;

D O I：

10.1080/14656566.2022.2122710

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1471 / 1474

页数：4

共 50 条

[41] Diagnosis and treatment of myasthenia gravis
Ponseti, JM
Espin, E
Armengol, M
MEDICINA CLINICA, 2000, 115 (07): : 264 - 270
[42] TREATMENT OF MYASTHENIA-GRAVIS
OSTERMAN, PO
AQUILONIUS, SM
PHARMACY INTERNATIONAL, 1985, 6 (04): : 94 - 97
[43] SURGICAL TREATMENT OF MYASTHENIA GRAVIS
CLAGETT, OT
EATON, LM
JOURNAL OF THORACIC SURGERY, 1947, 16 (01): : 62 - 80
[44] Acute treatment for myasthenia gravis
Nils Erik Gilhus
Nature Reviews Neurology, 2011, 7 : 132 - 134
[45] THE EMERGENCY TREATMENT OF MYASTHENIA GRAVIS
VIETS, HR
MEDICAL CLINICS OF NORTH AMERICA, 1946, (NBOST) : 1035 - 1041
[46] MESTINON IN THE TREATMENT OF MYASTHENIA GRAVIS
WESTERBERG, MR
MAGEE, KR
NEUROLOGY, 1954, 4 (10) : 762 - 772
[47] Treatment of juvenile myasthenia gravis
Arroyo, Hugo A.
MEDICINA-BUENOS AIRES, 2019, 79 : 71 - 76
[48] Ravulizumab for the treatment of myasthenia gravis
Vanoli, Fiammetta
Mantegazza, Renato
EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (03) : 235 - 241
[49] Current Treatment of Myasthenia Gravis
Alhaidar, Mohammed K.
Abumurad, Sumayyah
Soliven, Betty
Rezania, Kourosh
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (06)
[50] Treatment of Ocular Myasthenia Gravis
Cornblath, Wayne T.
ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2018, 7 (04): : 257 - 259